Wonju Severance Christian Hospital
Wŏnju, Kangwondo, 26426, South Korea
NCT Number: NCT07012499
Although peritoneal dialysis (PD) is a representative renal replacement therapy along with hemodialysis, number of PD patients decreases every year. Among the various contributing factors for such trends, the essential issue that the patients should perform dialytic therapy by themselves is thought to be critical for the patients to avoid choosing PD as primary dialytic therapy. In particular, unlike hemodialysis, the patients with PD have troubles in getting timely medical advice in their daily life, although continuous advice are essential for maintaining therapy. Thus, remote monitoring and control system is believed to be useful in PD therapy.
Automated PD (APD) is a good option because of its convenience and improved accessibility. So, in Korea, although the rate of incident PD patients was decreased, the proportion of APD were rapidly increased (3.7% in 2001 vs. 39% in 2018, Korean Society of Nephrology (KSN) data) In the COVID-19 pandemic, the investigators should improve Remote therapy monitoring (RTM). Technologies that collect medical information and transmit it to health care providers for patient management, have the potential to improve the patients' outcomes without visiting hospital receiving automated peritoneal dialysis (APD) at home. However, there are only a few retrospective studies and no prospective study about remote patients monitoring programs in APD. Remote medical service is currently illegal in South Korea. However, recently the Korean government has approved remote medical service in only a few areas of Gangwon province, including Wonju city, which belongs to our institution.
Thus, the investigators aim to use such a benefit to investigate the 'Quality of Life (QOL)' in Korean patients undergoing APD. The investigators plan to compare the various clinical indexes, including mainly QOL, mental health focusing depression, and volume-nutritional status between the patients with previous classic APD and APD combined by the SharesourceTM system (Baxter Co.).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Wŏnju, Kangwondo, 26426, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients receive APD with an FMC device that contains sharesource software which can communicate with the medical team.
Patients received APD with Same machine but this patients dose not using sharesource software
Time frame: 6, 12 months
Time frame: 6, 12 months
Time frame: 6, 12 months
Time frame: 6, 12 months
Time frame: 6, 12 months
Overhydration (measured by bioimpedance device)
Time frame: 6, 12 months
GNRI (geriatric nutrition risk index), Handgrip strength test (kg)
Time frame: 6,12 months
KT/V
Time frame: 6,12 months
change of PD perscription, personalized prescription changes, hospital admission, ER admission, unplanned hospital visit, exchanges over telephone
Time frame: 12 months
peritonitis, mechanical comlications
Time frame: 6 months, 12 months
Time frame: 90 Days
Total time of PD
Time frame: 12 month
Medical coast
Wonju Severance Christian Hospital
Other
The Investigation of Quality of Life and Mental Health Using Remote Monitoring System (Sharesource) With Automated Peritoneal Dialysis in End-stage Renal Disease Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05150990
Alzheimer Disease, Behavior
Calabasas, California, United States
View Trial DetailsNCT04668560
Mental Health Wellness 1, Quality of Life
Oslo, Norway
View Trial DetailsNCT04378452
Behavior, COVID-19
Badalona, Catalonia, Spain
View Trial DetailsNCT03258138
Behavior, Chronic Disease
Hamilton, Ontario, Canada
View Trial Details